CZ Vaccines — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

CZ Vaccines is a key CDMO within Spain's Zendal Group, providing end-to-end development and manufacturing services for viral, bacterial, and parasitic vaccines for human and animal health. The company boasts a versatile technology platform encompassing conventional, live attenuated, recombinant subunit, and DNA vaccines, supported by GMP-certified production facilities in Spain and Portugal. With a global reach to over 65 countries and a claim as a first producer in mycobacteria, CZ Vaccines positions itself as a strategic partner for biopharmaceutical companies and public health entities seeking large-scale, integrated vaccine production capabilities.

Infectious Disease

Technology Platform

Multi-platform vaccine developer and manufacturer. Capabilities include conventional vaccines, genetic engineering live attenuated vaccines, recombinant subunit vaccines, and DNA vaccines. Specialized expertise in mycobacteria production.

Opportunities

Growing global demand for vaccine manufacturing capacity, especially in Europe, driven by pandemic preparedness and regional health security initiatives.

Expansion opportunities in both human health CDMO services for novel vaccine platforms and in the growing animal health preventive care market.

Risk Factors

Heavy reliance on third-party contracts subjects the business to client concentration and project pipeline risks.

Stringent, evolving GMP regulations pose ongoing compliance challenges.

Competition from larger, global CDMOs and technological disruption from new platforms (e.g., mRNA) are constant threats.

Competitive Landscape

CZ Vaccines competes in the global biologics CDMO market against large players like Lonza, Catalent, and Recipharm, as well as other regional specialists. Its differentiation lies in its specific focus on multiple vaccine platforms, mycobacteria expertise, and its integrated position within the Zendal Group's biopharmaceutical ecosystem in Southern Europe.

More companies in Spain →